| RS1583605716 |
CSNK2B
|
Health Risk |
Pathogenic |
Poirier-Bienvenu neurodevelopmental syndrome, Poirier-Bienvenu neurodevelopmental syndrome |
| RS1583607800 |
LOC111365204;PRDM13
|
Health Risk |
Pathogenic/Likely pathogenic |
maculopathy, North Carolina macular dystrophy |
| RS1583608433 |
CSNK2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Poirier-Bienvenu neurodevelopmental syndrome, Poirier-Bienvenu neurodevelopmental syndrome |
| RS1583609839 |
LOC111365204
|
Health Risk |
Pathogenic |
Progressive bifocal chorioretinal atrophy, Progressive bifocal chorioretinal atrophy |
| RS1583610610 |
CSNK2B
|
Health Risk |
Pathogenic |
Poirier-Bienvenu neurodevelopmental syndrome, Poirier-Bienvenu neurodevelopmental syndrome |
| RS1583610622 |
CSNK2B
|
Health Risk |
Likely pathogenic |
Intellectual disability, Seizure |
| RS1583611290 |
CSNK2B
|
Health Risk |
Pathogenic |
Poirier-Bienvenu neurodevelopmental syndrome, Poirier-Bienvenu neurodevelopmental syndrome |
| RS1583611843 |
CSNK2B
|
Health Risk |
Pathogenic |
Poirier-Bienvenu neurodevelopmental syndrome, Poirier-Bienvenu neurodevelopmental syndrome |
| RS1583613268 |
CSNK2B
|
Health Risk |
Pathogenic |
Poirier-Bienvenu neurodevelopmental syndrome, Poirier-Bienvenu neurodevelopmental syndrome |
| RS1583616682 |
DNAH11
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1583647043 |
DNAH11
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1583657698 |
KLHL7
|
Health Risk |
Pathogenic/Likely pathogenic |
Bohring-Opitz syndrome, PERCHING syndrome |
| RS1583685951 |
DNAH11
|
Health Risk |
Likely pathogenic |
— |
| RS1583695322 |
FIG4
|
Health Risk |
Pathogenic/Likely pathogenic |
Amyotrophic lateral sclerosis type 11, Charcot-Marie-Tooth disease |
| RS1583695328 |
FIG4
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease type 4J |
| RS1583697607 |
FIG4
|
Health Risk |
Likely pathogenic |
— |
| RS1583725395 |
FKBP14
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, kyphoscoliotic type |
| RS1583728165 |
GLI3
|
Health Risk |
Pathogenic |
Greig cephalopolysyndactyly syndrome, Greig cephalopolysyndactyly syndrome |
| RS1583728402 |
GLI3
|
Health Risk |
Likely pathogenic |
Greig cephalopolysyndactyly syndrome, Greig cephalopolysyndactyly syndrome |
| RS1583728570 |
GLI3
|
Health Risk |
Pathogenic |
— |
| RS1583729398 |
GLI3
|
Health Risk |
Pathogenic |
Postaxial polydactyly, type A1/B |
| RS1583729562 |
GLI3
|
Health Risk |
Pathogenic |
Polysyndactyly 4, Polysyndactyly 4 |
| RS1583733628 |
KLHL7
|
Health Risk |
Pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS1583734240 |
GLI3
|
Health Risk |
Pathogenic |
Postaxial polydactyly type B, Postaxial polydactyly type B |
| RS1583734485 |
FKBP14
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, kyphoscoliotic type |
| RS1583738732 |
FKBP14
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, kyphoscoliotic type |
| RS1583747773 |
GLI3
|
Health Risk |
Pathogenic |
Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome |
| RS1583756552 |
LAMA2
|
Health Risk |
Pathogenic |
Merosin deficient congenital muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1583771680 |
LAMA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1JJ, Cardiovascular phenotype |
| RS1583790201 |
LAMA2
|
Health Risk |
Pathogenic/Likely pathogenic |
LAMA2-related muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS1583801167 |
GLI3
|
Health Risk |
Pathogenic |
Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome |
| RS1583805203 |
GLI3
|
Health Risk |
Pathogenic |
Pallister-Hall syndrome, Greig cephalopolysyndactyly syndrome |
| RS1583806864 |
DNAH11
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1583813573 |
LAMA2
|
Health Risk |
Pathogenic |
— |
| RS1583815667 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1583818052 |
ELN
|
Health Risk |
Conflicting classifications of pathogenicity |
Supravalvar aortic stenosis, Supravalvar aortic stenosis |
| RS1583818183 |
ELN
|
Health Risk |
Likely pathogenic |
Supravalvar aortic stenosis, Supravalvar aortic stenosis |
| RS1583819255 |
CCM2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cerebral cavernous malformation 2, Cerebral cavernous malformation 2 |
| RS1583819935 |
MPIG6B
|
Health Risk |
Pathogenic |
— |
| RS1583822018 |
ELN
|
Health Risk |
Likely pathogenic |
— |
| RS1583845651 |
LAMA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Muscular dystrophy, limb-girdle |
| RS1583873953 |
ELN
|
Health Risk |
Likely pathogenic |
— |
| RS1583879945 |
GUSB
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis type 7, Mucopolysaccharidosis type 7 |
| RS1583884979 |
NT5C3A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1583893433 |
CDK13
|
Health Risk |
Likely pathogenic |
Congenital heart defects, dysmorphic facial features |
| RS1583901813 |
CCM2
|
Health Risk |
Pathogenic |
— |
| RS1583913715 |
AUTS2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1583919688 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1583929127 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1583955795 |
GUSB
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis type 7, Mucopolysaccharidosis type 7 |
| RS1583959262 |
ELN
|
Health Risk |
Pathogenic |
Supravalvar aortic stenosis, Supravalvar aortic stenosis |
| RS1583964560 |
HSPB1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease |
| RS1583966508 |
HSPB1
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease |
| RS1583970495 |
CCM2
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation 2, Cerebral cavernous malformation 2 |
| RS1583972803 |
CDK13
|
Health Risk |
Likely pathogenic |
Congenital heart defects, dysmorphic facial features |
| RS1583981615 |
YWHAG
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 56 |
| RS1583981736 |
YWHAG
|
Health Risk |
Pathogenic |
8 conditions, Developmental and epileptic encephalopathy |
| RS1583983649 |
CCM2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cerebral cavernous malformation 2, Cerebral cavernous malformation |
| RS1583984070 |
CCM2
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation 2, Cerebral cavernous malformation 2 |
| RS1584026191 |
GARS1
|
Health Risk |
Likely pathogenic |
Neuronopathy, distal hereditary motor |
| RS1584028092 |
ASL
|
Health Risk |
Pathogenic |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS1584028936 |
ASL
|
Health Risk |
Pathogenic/Likely pathogenic |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS1584031242 |
ASL
|
Health Risk |
Likely pathogenic |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS1584032751 |
ASL
|
Health Risk |
Pathogenic |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS1584034430 |
GARS1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Neuronopathy |
| RS1584035995 |
CDK13
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital heart defects, dysmorphic facial features |
| RS1584062332 |
STX11
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 4, Familial hemophagocytic lymphohistiocytosis 4 |
| RS1584071201 |
PCLO
|
Health Risk |
Likely pathogenic |
Pontocerebellar hypoplasia type 3, Pontocerebellar hypoplasia type 3 |
| RS1584086882 |
CAMK2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Autism spectrum disorder, Autism spectrum disorder |
| RS1584100685 |
DST
|
Health Risk |
Pathogenic |
Hereditary sensory and autonomic neuropathy type 6, Epidermolysis bullosa simplex 3 |
| RS1584179629 |
BBS9
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1584203922 |
AP1S1
|
Health Risk |
Pathogenic/Likely pathogenic |
MEDNIK syndrome, MEDNIK syndrome |
| RS1584238193 |
EGFR
|
Health Risk |
Pathogenic |
Non-small cell lung carcinoma, Non-small cell lung carcinoma |
| RS1584251663 |
SAMD9
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1584251938 |
SAMD9
|
Health Risk |
Pathogenic |
MIRAGE syndrome, MIRAGE syndrome |
| RS1584253343 |
SAMD9
|
Health Risk |
Pathogenic |
MIRAGE syndrome, MIRAGE syndrome |
| RS1584253388 |
SAMD9
|
Health Risk |
Likely pathogenic |
MIRAGE syndrome, MIRAGE syndrome |
| RS1584254152 |
SAMD9
|
Health Risk |
Pathogenic |
MIRAGE syndrome, MIRAGE syndrome |
| RS1584254471 |
SAMD9
|
Health Risk |
Likely pathogenic |
— |
| RS1584261177 |
ACTB
|
Health Risk |
Likely pathogenic |
— |
| RS1584261979 |
ACTB
|
Health Risk |
Pathogenic |
Baraitser-Winter syndrome 1, Baraitser-Winter syndrome 1 |
| RS1584262037 |
ACTB
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1584263049 |
ACTB
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS1584292992 |
SLC26A4
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 4, Autosomal recessive nonsyndromic hearing loss 4 |
| RS1584306754 |
SLC26A4
|
Health Risk |
Likely pathogenic |
— |
| RS1584315950 |
COL1A2
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1584316181 |
COL1A2
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta, Osteogenesis imperfecta |
| RS1584317722 |
SLC26A4
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 4, Autosomal recessive nonsyndromic hearing loss 4 |
| RS1584318303 |
COL1A2
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1584318648 |
COL1A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1584318953 |
COL1A2
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta, Osteogenesis imperfecta |
| RS1584318956 |
COL1A2
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1584319045 |
COL1A2
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1584319418 |
COL1A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Osteogenesis imperfecta, Osteogenesis imperfecta type III |
| RS1584319922 |
COL1A2
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1584320246 |
COL1A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta type III, Osteogenesis imperfecta type I |
| RS1584320553 |
COL1A2
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS1584320605 |
COL1A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Ehlers-Danlos syndrome, arthrochalasia type |
| RS1584321194 |
COL1A2
|
Health Risk |
Likely pathogenic |
— |
| RS1584322496 |
COL1A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta type III, Osteogenesis imperfecta |